Ep. 22 - Oral GLP-1 Breakthroughs and the Future of Weight Loss Artwork

The Scalpel's Edge

The Scalpel's Edge is a podcast hosted by Dr. Tim Sayed, a leading plastic surgeon and physician innovator, dedicated to exploring the forefront of excellence and wellness. The show delves into cutting-edge medical technologies, industry controversies, and innovative approaches to healthcare and personal growth. With insightful discussions featuring top leaders and innovators from healthcare and beyond, the podcast aims to optimize performance, enhance wellness, and deepen self-understanding. Listeners can follow the podcast on platforms like Apple and Spotify to join this journey into groundbreaking advancements and out-of-the-box thinking.

All Episodes

The Scalpel's Edge

Ep. 22 - Oral GLP-1 Breakthroughs and the Future of Weight Loss

November 18, 2025

A new era of weight management is on the horizon. In this episode of The Scalpel’s Edge, learn how oral GLP-1 medications like semaglutide (Rebelsus) are changing the landscape of obesity care and cardiovascular health. Explore key findings from the OASIS-4 Phase 3 trial, new FDA updates, and what the data reveals about blood sugar control, heart health, and weight reduction across all age groups. Discover why oral options may soon rival injectables like Ozempic, Wegovy, and Mounjaro—and what this means for the millions of people seeking sustainable wellness solutions.

Contact Dr. Tim Sayed:
Phone: (858) 247-2933
Email: info@timsayedmd.com
Website: timsayedmd.com
Instagram: @timsayedmd
YouTube: @Timsayedmd
Facebook: Tim Sayed MD